Show simple item record

dc.contributor.advisorLubis, Yuliani M
dc.contributor.advisorSaragih, Muhammad Arfiza Putra
dc.contributor.authorNasution, Erizal Salam Putra
dc.date.accessioned2025-07-15T08:02:50Z
dc.date.available2025-07-15T08:02:50Z
dc.date.issued2025
dc.identifier.urihttps://repositori.usu.ac.id/handle/123456789/105497
dc.description.abstractThe Risk of Hearing Impairment in Beta Thalassemia Major Patients in RSUP H. Adam Malik Abstract Background: Beta thalassemia major is a hereditary anemia disorder with a global prevalence of approximately 1 in 100,000 live births, more common in Southeast Asia including Indonesia. The disease causes various serious complications, including hearing impairment with varying prevalence. Hearing impairment occurs in more than 27% of pediatric patients undergoing iron chelation therapy, which can interfere with communication and cognitive function. Purpose: This study aims to examine the relationship between age, disease duration, transfusion frequency, ferritin levels, and hemoglobin with hearing impairment in pediatric patients with beta thalassemia major. Methods: This study used a cross-sectional design with a sample of 60 pediatric patients with beta thalassemia major. Collected data included age, disease duration, transfusion frequency, ferritin levels, hemoglobin, and hearing function examination results. Results: A total of 43.3% of patients experienced hearing impairment, with 16.7% having bilateral impairment. Analysis showed a significant relationship between patient age and risk of hearing impairment (OR 4.222 for age >10 years, p = 0.011). In addition, transfusion frequency was also significantly associated with hearing impairment (p = 0.049). However, ferritin levels (p = 0.715), hemoglobin levels (p = 0.511), and disease duration (p = 0.088) showed no significant relationship. Conclusion: Hearing impairment is a common complication in beta thalassemia major patients. Age and transfusion frequency are significant predictor factors for hearing impairment, while ferritin levels, hemoglobin levels, and disease duration show no significant relationship. Therefore, regular monitoring of hearing function is crucial, especially for older patients and those with high transfusion frequency, to reduce the impact of this complication. Keywords: Beta thalassemia major, hearing impairment, risk factorsen_US
dc.language.isoiden_US
dc.publisherUniversitas Sumatera Utaraen_US
dc.subjectBeta thalassemia majoren_US
dc.subjecthearing impairmenten_US
dc.subjectrisk factorsen_US
dc.titleResiko Gangguan Pendengaran pada Penderita Thalasemia Beta Mayor di RSUP. H. Adam Maliken_US
dc.title.alternativeThe Risk of Hearing Impairment in Beta Thalassemia Major Patients in RSUP H. Adam Maliken_US
dc.typeThesisen_US
dc.identifier.nimNIM197109002
dc.identifier.nidnNIDN0027078807
dc.identifier.kodeprodiKODEPRODI12708#Ilmu Kesehatan Telinga Hidung Tenggorok, Bedah Kepala dan Leher
dc.description.pages115 Pagesen_US
dc.description.typeTesis Magisteren_US
dc.subject.sdgsSDGs 4. Quality Educationen_US


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record